SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/AD332BC8AEC3AF844BB6DD87C4E56D8FD4FD5F45330AE86F86653F8BDDF1C5C05CDBC1BF8625063F1A0A3E1CCB9E8A8C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/AD332BC8AEC3AF844BB6DD87C4E56D8FD4FD5F45330AE86F86653F8BDDF1C5C05CDBC1BF8625063F1A0A3E1CCB9E8A8C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/AD332BC8AEC3AF844BB6DD87C4E56D8FD4FD5F45330AE86F86653F8BDDF1C5C05CDBC1BF8625063F1A0A3E1CCB9E8A8C
http://www.w3.org/2000/01/rdf-schema#comment
"Cysteine 481 to serine BTK mutation confers ibrutinib resistance of chronic lymphocytic leukemia cells."
xsd:string
http://purl.uniprot.org/uniprot/#_332C9B07A5D76FF451D3D7B33D670CF5371771B12DE5964CDFD7B6672BE1F9873EB26DD21E167F11EED46CE9CE1F7A1A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/AD332BC8AEC3AF844BB6DD87C4E56D8FD4FD5F45330AE86F86653F8BDDF1C5C05CDBC1BF8625063F1A0A3E1CCB9E8A8C
http://purl.uniprot.org/uniprot/Q9P0L7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AD332BC8AEC3AF844BB6DD87C4E56D8FD4FD5F45330AE86F86653F8BDDF1C5C05CDBC1BF8625063F1A0A3E1CCB9E8A8C
http://purl.uniprot.org/uniprot/#_Q9P0L7-mappedCitation-25189416
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AD332BC8AEC3AF844BB6DD87C4E56D8FD4FD5F45330AE86F86653F8BDDF1C5C05CDBC1BF8625063F1A0A3E1CCB9E8A8C